Article metrics


A randomised controlled trial of gemcitabine hydrochloride plus S-1 combination therapy versus gemcitabine hydrochloride therapy alone in pancreatic cancer patients aged ≥75 years: a study protocol for an open-label randomised feasibility study

Statistics from

Online download statistics by month:

Online download statistics by month: February 2018 to July 2018

Feb 201893757
Mar 20181271297
Apr 201891917
May 201883834
Jun 201885852
Jul 201893927